Ocular Therapeutix (OCUL) Equity Ratio (2013 - 2026)

Ocular Therapeutix's quarterly Equity Ratio came in at 0.79 in Q1 2026, up 21.19% year-on-year from 0.66 in Q1 2025, and down 1.95% quarter-over-quarter from 0.81 in Q4 2025.

Ocular Therapeutix has reported Equity Ratio for 14 years, with the latest figure at 0.79 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio rose 21.19% year-over-year to 0.79; the trailing twelve-month figure through Mar 2026 stood at 0.79 (up 21.19% YoY), and the FY2025 full-year result was 0.81, up 17.59% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.79, down from 0.81 in the prior quarter.
  • The five-year high for Equity Ratio was 0.81 in Q4 2025, with the low at 0.03 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.49, with a median of 0.63 recorded in 2025.
  • Year-over-year, Equity Ratio plunged 93.38% in 2023 and soared 2799.88% in 2024.
  • Tracing OCUL's Equity Ratio over 5 years: stood at 0.24 in 2022, then surged by 52.56% to 0.36 in 2023, then soared by 90.47% to 0.69 in 2024, then advanced by 17.59% to 0.81 in 2025, then decreased by 1.95% to 0.79 in 2026.
  • The last three Equity Ratio figures came in at 0.79 (Q1 2026), 0.81 (Q4 2025), and 0.63 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Ocular Therapeutix 1.99 Bn 1.99 Bn 9.46 Mn 0.79

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.79
Dec 31, 2025 0.81
Sep 30, 2025 0.63
Jun 30, 2025 0.68
Mar 31, 2025 0.66
Dec 31, 2024 0.69
Sep 30, 2024 0.72
Jun 30, 2024 0.73
Mar 31, 2024 0.76
Dec 31, 2023 0.36
Sep 30, 2023 0.05
Jun 30, 2023 0.03
Mar 31, 2023 0.08
Dec 31, 2022 0.24
Sep 30, 2022 0.29
Jun 30, 2022 0.38
Mar 31, 2022 0.43
Dec 31, 2021 0.43
Sep 30, 2021 0.40
Jun 30, 2021 0.35
Mar 31, 2021 0.34
Dec 31, 2020 0.29
Sep 30, 2020 -0.04
Jun 30, 2020 0.05
Mar 31, 2020 -0.15
Dec 31, 2019 -0.05
Sep 30, 2019 0.13
Jun 30, 2019 0.09
Mar 31, 2019 0.25
Dec 31, 2018 0.49
Sep 30, 2018 0.65
Jun 30, 2018 0.65
Mar 31, 2018 0.64
Dec 31, 2017 0.47
Sep 30, 2017 0.56
Jun 30, 2017 0.60
Mar 31, 2017 0.70
Dec 31, 2016 0.69
Sep 30, 2016 0.76
Jun 30, 2016 0.78
Mar 31, 2016 0.80
Dec 31, 2015 0.81
Sep 30, 2015 0.83
Jun 30, 2015 0.84
Mar 31, 2015 0.73
Dec 31, 2014 0.75
Sep 30, 2014 0.78
Jun 30, 2014 -2.90
Dec 31, 2013 -3.11